HPV jabs will not be 'cost-effective' for boys

Cervical cancer US study finds that high uptake among girls eliminates the case for vaccinating boys as well.

HPV jabs for boys would not be cost-effective if there is a high enough uptake among girls, say US researchers.

Latest figures from the NHS Information Centre show that 70 per cent of eligible 12- to 13-year-old girls received all three doses, and 87 per cent one dose, in 2008/9.

Future uptake levels could be hit after a 14-year old Coventry girl died shortly after receiving an HPV jab at school last month, although a post-mortem later found her death was caused by a malignant tumour.

Earlier this year, experts warned that the DoH may be forced to add boys to the HPV vaccination programme to hit the uptake levels required for herd immunity (GP, 3 April).

For this study, researchers from Harvard University in Boston conducted a cost-effectiveness analysis to compare HPV vaccination of pre-adolescent girls alone with vaccination of both girls and boys.

They used NICE's preferred cost-effectiveness benchmark - cost per 'quality adjusted life year' (QALY). Vaccination was considered to be value for money if it cost between £31,172 and £62,344 per extra QALY.

Overall, they found that while the vaccination of 12-year-old girls was cost-effective, including boys in the vaccination programme surpassed the upper QALY threshold.

The researchers concluded: 'Our results suggest that if vaccine coverage and efficacy are high among pre-adolescent girls, including boys in an HPV programme is unlikely to provide comparatively good value for resources.'

 

GP Online recommends

BMJ Online 2009

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 alert level raised as GPs prioritised for testing

UK COVID-19 alert level raised as GPs prioritised for testing

The government has raised the UK's COVID-19 alert level to four amid reports that...

UK on course for 50,000 COVID-19 cases a day by mid-October

UK on course for 50,000 COVID-19 cases a day by mid-October

The UK could see 50,000 COVID-19 cases per day by mid-October, with the epidemic...

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

COVID-19 infection rates will ‘soar’ and the NHS will ‘once again be crippled’ if...

Practices handed one-month opt-out window as revamped network DES unveiled

Practices handed one-month opt-out window as revamped network DES unveiled

NHS England has unveiled a revamped DES package for 2020/21 confirming new targets,...

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered a huge increase in face-to-face appointments in the week before NHS...

RCGP facing legal action over stance on assisted dying

RCGP facing legal action over stance on assisted dying

The RCGP is facing legal action over its decision to remain opposed to assisted dying...